Review article · 2023 · Open access
Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease
CNS Neuroscience & Therapeutics, 29(8), 2060–2073 · Published 5 May 2023 · DOI 10.1111/cns.14238
In brief
“Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease” is a 2023 review article by Yanan Xu and 7 co-authors, published in CNS Neuroscience & Therapeutics. OpenAlex counts 11 citations as of 19 November 2026, which puts it in the top 7% of works published in 2023 by citations. It is open access under a CC BY licence: the full text is free to read at CNS Neuroscience & Therapeutics.
- Citations
- 11
- Most cited in
- 2026 (5)
- Field-weighted impact
- 0.30
- References
- 149
- Authors
- 8
Abstract
AIMS: Alzheimer's disease (AD) is a neurodegenerative disease with challenging early diagnosis and effective treatments due to its complex pathogenesis. AD patients are often diagnosed after the appearance of the typical symptoms, thereby delaying the best opportunity for effective measures. Biomarkers could be the key to resolving the challenge. This review aims to provide an overview of application and potential value of AD biomarkers in fluids, including cerebrospinal fluid, blood, and saliva, in diagnosis and treatment. METHODS: A comprehensive search of the relevant literature was conducted to summarize potential biomarkers for AD in fluids. The paper further explored the biomarkers' utility in disease diagnosis and drug target development. RESULTS: , total Tau (t-Tau), and phosphorylated Tau (p-Tau), have been endorsed for their diagnostic and predictive capability. However, other biomarkers remain controversial. Drugs targeting Aβ have shown some efficacy and those that target BACE1 and Tau are still undergoing development. CONCLUSION: Fluid biomarkers hold considerable potential in the diagnosis and drug development of AD. However, improvements in sensitivity and specificity, and approaches for managing sample impurities, need to be addressed for better diagnosis.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Xu, Y., Jiang, H., Zhu, B., Cao, M., Feng, T., Sun, Z., Du, G., & Zhao, Z. (2023). Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease. CNS Neuroscience & Therapeutics, 29(8), 2060–2073. https://doi.org/10.1111/cns.14238
MLA 9
Xu, Yanan, et al. “Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease.” CNS Neuroscience & Therapeutics, vol. 29, no. 8, 2023, pp. 2060–2073. https://doi.org/10.1111/cns.14238.
Chicago
Xu, Yanan, Hailun Jiang, Bin Zhu, Mingnan Cao, Tao Feng, Zhongshi Sun, Guanhua Du, and Zhigang Zhao. 2023. “Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease.” CNS Neuroscience & Therapeutics 29 (8): 2060–2073. https://doi.org/10.1111/cns.14238.
Harvard
Xu, Y. et al. (2023) ‘Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease’, CNS Neuroscience & Therapeutics, 29(8), pp. 2060–2073. doi:10.1111/cns.14238.
IEEE
Y. Xu et al., “Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease,” CNS Neuroscience & Therapeutics, vol. 29, no. 8, pp. 2060–2073, 2023, doi: 10.1111/cns.14238.
BibTeX
@article{xu2023advances,
title = {{Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease}},
author = {Xu, Yanan and Jiang, Hailun and Zhu, Bin and Cao, Mingnan and Feng, Tao and Sun, Zhongshi and Du, Guanhua and Zhao, Zhigang},
journal = {CNS Neuroscience \& Therapeutics},
year = {2023},
volume = {29},
number = {8},
pages = {2060--2073},
doi = {10.1111/cns.14238},
url = {https://doi.org/10.1111/cns.14238}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2023 | 2 | |
| 2024 | 2 | |
| 2025 | 2 | |
| 2026 | 5 |
Its field-weighted citation impact is 0.30: it has been cited 0.30 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Alzheimer's disease
- fluid biomarkers
- cerebrospinal fluid
- blood biomarkers
- salivary biomarkers
- total tau
- phosphorylated tau
- amyloid-beta
Work with this paper
Most-cited papers in Neuroscience
- The Rat Brain in Stereotaxic CoordinatesGeorge Paxinos, CHARLES R. R. WATSON · Elsevier eBooks · 1982 · 52,413 citations
- The assessment and analysis of handedness: The Edinburgh inventoryRichard Charles Oldfield · Neuropsychologia · 1971 · 36,725 citations
- EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysisArnaud Delorme A, Scott Makeig · Journal of Neuroscience Methods · 2004 · 25,302 citations
- The Ecological Approach to Visual PerceptionMarc H. Bornstein, James J. Gibson · Journal of Aesthetics and Art Criticism · 1980 · 22,977 citations
- The Psychophysics ToolboxDavid H. Brainard · Spatial Vision · 1997 · 20,208 citations
Questions about this paper
How do I cite this paper in APA style?
Xu, Y., Jiang, H., Zhu, B., Cao, M., Feng, T., Sun, Z., Du, G., & Zhao, Z. (2023). Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease. CNS Neuroscience & Therapeutics, 29(8), 2060–2073. https://doi.org/10.1111/cns.14238
How many times has this paper been cited?
11 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at CNS Neuroscience & Therapeutics: sign in and open the PDF from this page.
Who wrote this paper?
Yanan Xu, Hailun Jiang, Bin Zhu, Mingnan Cao, Tao Feng, Zhongshi Sun, Guanhua Du, Zhigang Zhao.
What is the DOI of this paper?
10.1111/cns.14238, permanently at https://doi.org/10.1111/cns.14238. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.